Previous 10 | Next 10 |
2024-01-13 12:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Markets appear to have...
2024-01-09 14:03:03 ET Summary Today, we revisit Maravai LifeSciences Holdings, Inc. for the first time since early in 2023. The company continues to see some buyout speculation and is still dealing with navigating the "Covid Cliff" that has deeply impacted revenues. Maravai r...
2023-12-30 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-12 12:34:39 ET More on Maravai LifeSciences Holdings Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript Maravai LifeSciences Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation Maravai LifeSciences: Falling Victim To COVID B...
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November. On November ...
2023-11-08 13:50:01 ET More on Maravai LifeSciences Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript Maravai LifeSciences Holdings, Inc. 2023 Q3 - Results - Earnings Call Presentation Maravai LifeSciences: Falling Victim To COVID Boom And B...
2023-11-08 03:54:03 ET Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Conference Call November 7, 2023 17:00 ET Company Participants Deb Hart - Investor Relations Trey Martin - Chief Executive Officer Kevin Herde - Chief Financial Officer Drew Bu...
2023-11-08 00:00:15 ET Image source: The Motley Fool. Maravai LifeSciences (NASDAQ: MRVI) Q3 2023 Earnings Call Nov 07, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Tr...
2023-11-07 16:28:02 ET More on Maravai LifeSciences Holdings Maravai LifeSciences: Falling Victim To COVID Boom And Bust Maravai LifeSciences Holdings Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Maravai LifeSciences Holdings Historical ear...
Announces Realignment to Drive Operational Efficiencies and Streamline the Business Post-Pandemic Continued Focus on Expanding Product Portfolio, Market Leadership and Scientific Innovation SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...
2024-05-29 15:15:03 ET RBC Capital analyst issues OUTPERFORM recommendation for MRVI on May 29, 2024 01:35PM ET. The previous analyst recommendation was Outperform. MRVI was trading at $8.87 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...